US Stock MarketDetailed Quotes

LULU Lululemon Athletica

Watchlist

392.920
-0.540-0.14%

Close Jan 8 16:00 ET

392.920
0.0000.00%

Post 20:01 ET

47.85BMarket Cap28.41P/E (TTM)

Lululemon Athletica Key Stats

Lululemon Athletica Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/Q1	-- / 2.395B	--
--	2025/Q4	-- / 3.521B	--
Dec 5, 2024	2025/Q3	2.397B / 2.357B	--
Aug 29, 2024	2025/Q2	2.371B / 2.408B	--
Jun 5, 2024	2025/Q1	2.209B / 2.197B	--

DatePeriodRevenue/EstimateEarnings Call

--2026/Q1-- / 2.395B--

--2025/Q4-- / 3.521B--

Dec 5, 20242025/Q32.397B / 2.357B--

Aug 29, 20242025/Q22.371B / 2.408B--

Jun 5, 20242025/Q12.209B / 2.197B

Lululemon Q1 2024 earnings conference call

Jun 5 15:30

Replay

Unlock Free Earnings Estimates

Open Account

Lululemon Athletica Earnings Reports

Lululemon Athletica | 10-Q: Q3 2025 Earnings Report

Dec 5, 2024 16:21 ET

Lululemon Athletica | 8-K: LULULEMON ATHLETICA INC. ANNOUNCES THIRD QUARTER FISCAL 2024 RESULTS BOARD OF DIRECTORS AUTHORIZES $1.0 BILLION INCREASE IN ITS STOCK REPURCHASE PROGRAM

Dec 5, 2024 16:15 ET

Lululemon Athletica | 10-Q: Q2 2025 Earnings Report

Aug 29, 2024 16:21 ET

Lululemon Athletica | 8-K: LULULEMON ATHLETICA INC. ANNOUNCES SECOND QUARTER FISCAL 2024 RESULTS Revenue increased 7% to $2.4 billion Comparable sales increased 2%, or 3% on a constant dollar basis Diluted EPS of $3.15

Aug 29, 2024 16:16 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Halozyme Therapeutics

HALO

+5.02%